Evrysdi is a survival motor neuron-2 (SMN2) splicing modifier.
The Lancet Commission added 3 new risk factors for dementia that coupled with the previous 9 lifestyle risk factors might prevent or delay up to 40% of dementias worldwide.
COVID-19 is associated with large vessel occlusion strokes.
Among health care providers in the New York City area, 13.7% have SARS-CoV-2 antibodies, a rate similar to adults randomly tested in New York state.
Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.
Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.
The ADVANCE study included 910 adults who experienced 4 to 14 migraines per month.
Annualized relapse rates are lower for patients with relapsing MS receiving anti-CD20 monoclonal antibody ofatumumab compared with teriflunomide.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.